The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...
Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...
Airway smooth muscle (ASM) lies at the core of bronchomotor tone and undergoes profound alterations in chronic airway diseases. In asthma and chronic obstructive pulmonary disease (COPD), ASM exhibits ...
Chronic obstructive pulmonary disease (COPD), or the deposition of black tar in the lungs, is different from asthma. Asthma is predominantly an allergic disease caused by a combination of genetic and ...
Pulmonary surfactant is a complex lipid–protein mixture that coats the alveolar surface, reducing surface tension and preventing alveolar collapse at end-expiration. Its principal lipid component, ...
Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four major ...
Why is it that we have not seen the urgency in COPD management we would expect for a disease of this burden and scale? As a trained pulmonologist, and having dedicated my career to advancing ...
A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...
Hosted on MSN
How To Tell the Difference Between Asthma and COPD
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that cause breathing difficulty and coughing. Both conditions share similar symptoms. Understanding their ...
Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that causes inflammation and lung damage. Lifestyle changes such as an anti-inflammatory diet and supplements can help manage ...
Patients with COPD who travel to high altitudes have an estimated PaO2 decrease of 0.84 kPa with each 1000 meter of altitude gain. High-altitude travel in patients with chronic obstructive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results